好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Heterogenous neuropathology in a pedigree with RAB39B-related Parkinson's disease
Movement Disorders
P8 - Poster Session 8 (11:45 AM-12:45 PM)
5-004

To characterize the neuropathological findings of two affected individuals in a multi-incident US kindred with RAB39B-related Parkinson’s disease (PD)

We previously reported a family with a classic PD phenotype in which a missense mutation in the RAB39B gene (c.574G > A; p.G192R) segregated with disease. Seven individuals (5 males and 2 females) were affected with a mean age at onset of 46.1 years. The pattern of inheritance was X-linked dominant with reduced penetrance in females.

Since our original report, two of the affected males are now deceased and have undergone autopsy. The younger brother (deceased at age 54) had unilateral symptom onset at age 31 and was levodopa responsive with later development of severe dyskinesias and psychiatric symptoms. The older brother (deceased at age 65) was diagnosed with PD in his early 50s, and his symptoms were levodopa responsive as well; he similarly experienced dyskinesias and psychosis.

NA

Tissue sections were obtained from the cortical lobes, brainstem, and basal ganglia. Immunohistochemical assessments included stains for α-synuclein, phospho-tau, phospho-TDP-43, and amyloid ß. The younger brother had Lewy body pathology in a neocortical distribution as expected, but also had an unusual pattern and burden of tau pathology that included neocortical neurofibrillary tangles, pretangles, and neurites in the absence of amyloid pathology. The older brother’s brain, while showing a similar pattern of tau pathology, was notable for a lack of α-synuclein pathology. Both cases showed marked pallor of the substantia nigra and severe loss of pigmented neurons with associated gliosis.

The pathology underlying monogenic forms of parkinsonism can include α-synuclein, tau, or other proteotoxic proteins, but the pathological findings are typically consistent within each disorder.  In contrast, these two cases displayed striking pathologic heterogeneity which suggests that the molecular processes underlying RAB39B-related neurodegeneration might be variable and complex. 

Authors/Disclosures
Kimmy Su, MD (University of Washington Medical Center)
PRESENTER
Dr. Su has nothing to disclose.
No disclosure on file
No disclosure on file
Dirk Keene, MD, PhD Dirk Keene, MD, PhD has received publishing royalties from a publication relating to health care.
Cyrus P. Zabetian, MD (VA Puget Sound Health Care System) The institution of Dr. Zabetian has received research support from American Parkinson Disease Association. The institution of Dr. Zabetian has received research support from Department of Veterans Affairs. The institution of Dr. Zabetian has received research support from NIH. Dr. Zabetian has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.